%0 Journal Article
%B The Lancet Neurology
%D 2018
%P 1053 - 1060
%T Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
%V 17